malondialdehyde has been researched along with Substance Withdrawal Syndrome in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (47.06) | 29.6817 |
| 2010's | 7 (41.18) | 24.3611 |
| 2020's | 2 (11.76) | 2.80 |
| Authors | Studies |
|---|---|
| El-Tahawy, NF; Hafez, EM; Paulis, MG | 1 |
| Arab Firozjae, A; Assadpour, S; Ghorbanzadeh, B; Goudarzi, M; Houshmand, G; Manouchehr, F; Nikbakht, J; Pourasghar, M; Shiran, M; Shirzad, S | 1 |
| Barakat, A; Elbadr, MM; Hamdy, MM | 1 |
| Chen, H; Gu, Y; He, J; Luan, X; Lv, D; Qiu, H; Ren, W; Shen, H; Su, H; Zhang, J; Zhao, K | 1 |
| Cighetti, G; Pinelli, A; Trivulzio, S | 2 |
| Chen, CC; Chen, CH; Huang, MC; Peng, FC; Tang, SH | 2 |
| Accinni, R; Cighetti, G; Pinelli, A; Trivulzio, S | 1 |
| Birdane, YO; Bulut, S; Büyükokuroğlu, ME; Cemek, M; Hazman, O; Konuk, M | 1 |
| Chen, CC; Chen, CH; Huang, MC; Pan, CH | 1 |
| Chao, JC; Chen, JR; Chien, YW; Lin, HS; Peng, HC; Yang, HY | 1 |
| Abdel-Rahman, MS; Abdel-Zaher, AO; Elwasei, FM | 1 |
| Abdel-Zaher, AO; Al-Shaibani, NK; Farghly, HM; Hamdy, MM; Mostafa, MG; Omran, GA | 1 |
| Aki, OE; Erbaş, D; Etik, C; Karakiliç, H; Uzbay, IT; Yuksel, N | 1 |
| Jung, ME; Simpkins, JW; Wilson, AM | 1 |
| Li, B; Li, G; Lin, H; Wang, Z; Xu, B; Zheng, Q; Zheng, R | 1 |
17 other study(ies) available for malondialdehyde and Substance Withdrawal Syndrome
| Article | Year |
|---|---|
Toxicity and postwithdrawal effects of ketamine on the reproductive function of male albino rats: Hormonal, histological, and immunohistochemical study.
Topics: Analgesics; Animals; Caspase 3; Follicle Stimulating Hormone; Ketamine; Luteinizing Hormone; Male; Malondialdehyde; Prolactin; Rats, Wistar; Reproduction; Spermatozoa; Substance Withdrawal Syndrome; Testis; Testosterone; Vimentin | 2020 |
Simvastatin prevents morphine antinociceptive tolerance and withdrawal symptoms through antioxidative effect and nitric oxide pathway in mice.
Topics: Animals; Antioxidants; Cerebral Cortex; Drug Tolerance; Hippocampus; Male; Malondialdehyde; Mice; Morphine Dependence; Nitric Oxide; Oxidative Stress; Signal Transduction; Simvastatin; Substance Withdrawal Syndrome | 2021 |
Bupropion attenuates morphine tolerance and dependence: Possible role of glutamate, norepinephrine, inflammation, and oxidative stress.
Topics: Animals; Brain; Bupropion; Dose-Response Relationship, Drug; Drug Tolerance; Glutamic Acid; Glutathione; Inflammation; Male; Malondialdehyde; Mice; Morphine; Morphine Dependence; Naloxone; Nitric Oxide; Norepinephrine; Organophosphorus Compounds; Oxidative Stress; Pain Measurement; Substance Withdrawal Syndrome | 2018 |
Association between serum malondialdehyde levels and depression during early methamphetamine withdrawal.
Topics: Adult; Amphetamine-Related Disorders; Biomarkers; Central Nervous System Stimulants; Depression; Female; Humans; Male; Malondialdehyde; Methamphetamine; Substance Withdrawal Syndrome; Young Adult | 2018 |
Plasma malondialdehyde levels and opiate withdrawal signs observed in rats treated with morphine plus naloxone: effects of alpha-lipoic acid administration.
Topics: Animals; Antioxidants; Behavior, Animal; Defecation; Dose-Response Relationship, Drug; Drug Interactions; Gas Chromatography-Mass Spectrometry; Male; Malondialdehyde; Morphine; Naloxone; Narcotic Antagonists; Narcotics; Oxidative Stress; Pain Threshold; Rats; Rats, Sprague-Dawley; Substance Withdrawal Syndrome; Thioctic Acid | 2008 |
The correlation between early alcohol withdrawal severity and oxidative stress in patients with alcohol dependence.
Topics: Adult; Alcoholism; Humans; Malondialdehyde; Oxidative Stress; Severity of Illness Index; Substance Withdrawal Syndrome; Superoxide Dismutase; Time Factors | 2009 |
Morphine or its withdrawal affects plasma malondialdehyde, vitamin E levels and absence or presence of abstinence signs in rats.
Topics: Animals; Isoproterenol; Male; Malondialdehyde; Morphine; Naloxone; Narcotic Antagonists; Narcotics; Rabbits; Random Allocation; Rats; Rats, Sprague-Dawley; Substance Withdrawal Syndrome; Vitamin E | 2009 |
Effects of alpha-lipoic acid administration on plasma glucose levels, total malondialdehyde values and withdrawal signs in rats treated with morphine or morphine plus naloxone.
Topics: Analgesics, Opioid; Animals; Antioxidants; Behavior, Animal; Blood Glucose; Defecation; Male; Malondialdehyde; Morphine; Morphine Dependence; Naloxone; Narcotic Antagonists; Rats; Rats, Sprague-Dawley; Substance Withdrawal Syndrome; Thioctic Acid | 2009 |
Alterations in oxidative stress status during early alcohol withdrawal in alcoholic patients.
Topics: Adult; Alcoholics; Alcoholism; Catalase; Female; Glutathione Peroxidase; Humans; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Substance Withdrawal Syndrome; Superoxide Dismutase | 2009 |
The roles of melatonin and vitamin E plus selenium in prevention of oxidative stress induced by naloxone-precipitated withdrawal in heroin-addicted rats.
Topics: Animals; Antioxidants; Ceruloplasmin; Glutathione; Heroin; Heroin Dependence; Lipid Peroxidation; Male; Malondialdehyde; Melatonin; Naloxone; Nitrates; Nitrites; Oxidative Stress; Rats; Rats, Sprague-Dawley; Selenium; Substance Withdrawal Syndrome; Vitamin E | 2011 |
Increased oxidative DNA damage in patients with alcohol dependence and its correlation with alcohol withdrawal severity.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Adult; Alcoholism; Deoxyguanosine; DNA Damage; Female; Humans; Liver Function Tests; Male; Malondialdehyde; Middle Aged; Oxidation-Reduction; Oxidative Stress; Psychiatric Status Rating Scales; Reactive Oxygen Species; Severity of Illness Index; Substance Withdrawal Syndrome; Young Adult | 2011 |
Effects of soy protein on alcoholic liver disease in rats undergoing ethanol withdrawal.
Topics: Animals; Cholesterol; Cytochrome P-450 CYP2E1; Cytochrome P-450 CYP4A; Ethanol; Interleukin-6; Liver; Liver Diseases, Alcoholic; Male; Malondialdehyde; Oxidative Stress; PPAR alpha; Rats; Rats, Wistar; Soybean Proteins; Substance Withdrawal Syndrome; Triglycerides; Tumor Necrosis Factor-alpha | 2012 |
Protective effect of Nigella sativa oil against tramadol-induced tolerance and dependence in mice: role of nitric oxide and oxidative stress.
Topics: Analgesics, Opioid; Animals; Antioxidants; Behavior, Animal; Brain; Drug Tolerance; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Glutamic Acid; Glutathione; Male; Malondialdehyde; Mice; Narcotic Antagonists; Nitric Oxide; Nitric Oxide Synthase; Nitrites; Opioid-Related Disorders; Oxidative Stress; Pain Threshold; Plant Oils; Receptors, N-Methyl-D-Aspartate; Substance Withdrawal Syndrome; Time Factors; Tramadol | 2011 |
Inhibition of brain oxidative stress and inducible nitric oxide synthase expression by thymoquinone attenuates the development of morphine tolerance and dependence in mice.
Topics: Animals; Benzoquinones; Brain; Drug Tolerance; Glutamic Acid; Glutathione; Glutathione Peroxidase; Male; Malondialdehyde; Mice; Morphine Dependence; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type II; Nitrites; Oxidative Stress; Substance Withdrawal Syndrome | 2013 |
Increased serum nitrite/nitrate (NOx) and malondialdehyde (MDA) levels during alcohol withdrawal in alcoholic patients.
Topics: Adult; Alcoholism; Ethanol; Humans; Lipid Peroxidation; Male; Malondialdehyde; Nitric Oxide; Severity of Illness Index; Spectrophotometry; Substance Withdrawal Syndrome; Time Factors | 2005 |
A nonfeminizing estrogen analog protects against ethanol withdrawal toxicity in immortalized hippocampal cells.
Topics: Adamantane; Animals; Cell Line; Cell Survival; Cytoprotection; Estrogens; Estrone; Ethanol; Hippocampus; Lipid Peroxidation; Malondialdehyde; Protein Carbonylation; Substance Withdrawal Syndrome | 2006 |
Heroin-administered mice involved in oxidative stress and exogenous antioxidant-alleviated withdrawal syndrome.
Topics: Animals; Antioxidants; Brain; Brain Chemistry; Catalase; DNA Damage; Female; Glutathione Peroxidase; Heroin; Heroin Dependence; Injections, Intraperitoneal; Injections, Subcutaneous; Lymphocytes; Male; Malondialdehyde; Mice; Naloxone; Narcotic Antagonists; Narcotics; Oxidative Stress; Substance Withdrawal Syndrome; Superoxide Dismutase | 2006 |